Articles | Open Access | https://doi.org/10.55640/ijmm-03-10-08

FEATURES OF CLINICAL MANIFESTATION OF NECROTISING FASCIITIS IN PATIENTS WITH DIABETES MELLITUS

Okhunov Alisher Oripovich , Tashkent Medical Academy, Head of the Department of General and Pediatric Surgery-1, Doctor of Medical Sciences, professor, Tashkent, Uzbekistan
Korikhonov Dilshod Nasrulloxonovich , Tashkent Medical Academy, Department of General and Pediatric Surgery-1, Tashkent, Uzbekistan

Abstract

Interest in treating necrotising fasciitis in patients with diabetes mellitus is not decreasing, as evidenced by many publications devoted to this problem. Many methods of local treatment of necrotising fasciitis against the background of diabetes mellitus have been proposed, a variety of methods are used, including nanotechnological dressings, highly organised technologies, and physiotherapeutic procedures, as well as numerous single- and multi-component schemes, and new Medicines. At the same time, there are still no unified tactics for the treatment of necrotising fasciitis against the background of diabetes mellitus, the choice of the optimal intervention or combination in different phases of the inflammatory process has not been determined, which is not least due to the variety of approaches to presenting the results of treatment. To date, there is no standard for describing the features of the course of necrotising fasciitis against the background of diabetes mellitus. In connection with the above, this scientific article is devoted to the analysis of the clinical manifestation of necrotising fasciitis in patients with diabetes mellitus.

Keywords

Necrotising fasciitis, diabetes mellitus, clinical manifestation of the disease

References

Antimicrobial agents and related therapy. // In Pickering L.K., ed. Red book 2003 report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2003 p. 693-694

Arslan A., Pierre-Jerome C., Borthne A. Necrotizing fasciitis: unreliable MRJ findings in the preoperative diagnosis. // Euro J Neurol, 2000 — 36 -p. 139-143.

Barie P.S. Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score: useful tool or paralysis analysis. // Crit Care Med, 2004 — 32 — p. 1618-1619

Heitmann C., Pelzer M., Bickert В., Menke H., German G. Chirurgishes konzeptund ergebnisse bei nekrotisierender fasciitis. // Chirurg, 2001 -72-p. 168-173

Korkut M., Icoz G., Dayangac M., Akgun E. Outcome analysis in patients with Fournier's gangrene. // Dis Colon Rectum, 2003 46 - p. 649-652

Majeski J. A., John J. F. Jr. Necrotizing soft tissue infections: a guide to early diagnosis and initial therapy. // South. Medical Journal, 2003 Sep; 96 (9); p. 900 905

Okhunov, A. O. "Influence of granulocyte-colony-stimulating factor on the cytological picture of the wound in patients with purulent-inflammatory diseases of soft tissues on the background of diabetes mellitus." (2022).

Okhunov, A., et al. "Morphological Characteristics of Intestinal Vessels of Animals with an Experimental Model of Diabetes Mellitus Type 2 Complicated by Microangiopathy." Indian Journal of Forensic Medicine & Toxicology 14.4 (2020): 7348-7353.

Pulatov, U. I., et al. Morphological aspects of wounds in patients with purulent inflammation of soft tissues in diabetes mellitus and under the influence of granulocyte-colony-stimulating factor. Diss. 2022.

Stevens D.L., Bisno A.L., Chambers H.F. et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections // Clinical Infectious Diseases, 2005 41- p. 1373-1406

Wall D.B., Klein S.R., Black S., de Virgilio C. A. Simple model to help distinguish necrotising fasciitis from non-necrotising soft tissue infection. J Am Coll Surg, 2000 191 - p. 227—231

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

FEATURES OF CLINICAL MANIFESTATION OF NECROTISING FASCIITIS IN PATIENTS WITH DIABETES MELLITUS. (2024). International Journal of Modern Medicine, 3(10), 74-80. https://doi.org/10.55640/ijmm-03-10-08